The drug was approved in 2012 for cancer patients, but has since become an outsize moneymaker for Insys Therapeutics and has been prescribed more widely.
via NYT > Health http://ift.tt/1jqSB2H
via All Health and Fitness http://ift.tt/1jqT053
No comments:
Post a Comment